MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the quarter ending 2025-09-30, LH made $3,563,500K in revenue. $261,100K in net income. Net profit margin of 7.33%.

Income Overview

Revenue
$3,563,500K
Net Income
$261,100K
Net Profit Margin
7.33%
EPS
$3.12
Unit: Thousand (K) dollars
Revenue Breakdown
    • Diagnostics-Operating Segments
    • Biopharma Laboratory Services-Op...

Unit: Thousand (K) dollars (except for numbers of shares and EPS)
Income Statement
2025-09-30
2025-06-30
2025-03-31
2024-12-31
Revenues
3,563,500 3,527,300 3,345,100 3,329,400
Cost of revenues
2,538,400 2,481,100 2,397,100 2,433,100
Gross profit
1,025,100 1,046,200 948,000 896,300
Selling, general, and administrative expenses
552,400 579,300 546,000 595,200
Amortization of intangibles and other assets
69,500 68,300 69,600 70,400
Goodwill and other asset impairments
700 0 0 2,800
Restructuring and other charges
5,900 4,100 6,400 11,400
Operating income
396,600 394,500 326,000 216,500
Interest expense
56,000 57,100 56,000 63,400
Investment income
3,500 1,700 6,500 15,000
Equity method loss, net
-5,200 -1,700 -300 -700
Other, net
-1,900 -32,700 -1,000 16,400
Earnings from operations before income taxes
337,000 304,700 275,200 183,800
Provision for income taxes
75,500 66,400 62,200 40,200
Earnings from continuing operations
---143,600
Earnings from discontinued operations, net of tax
---0
Net earnings
261,500 238,300 213,000 143,600
Less net earnings attributable to the noncontrolling interest
400 400 200 200
Net earnings attributable to labcorp holdings inc
261,100 237,900 212,800 143,400
Basic earnings per share (in dollars per share)
3.14 2.85 2.54 1.72
Diluted earnings per share (in dollars per share)
3.12 2.84 2.52 1.72
Net earnings, basic (in shares)
83,100,000 83,400,000 83,600,000 -168,300,000
Weighted average number of shares outstanding, diluted
83,700,000 83,900,000 84,300,000 -169,000,000
Unit: Thousand (K) dollars (except for numbers of shares and EPS)

Time Plot

Show the time plot by selecting a row from the table.

Income Statement

DownloadDownload image
Biopharma LaboratoryServices-Operating Segments$799,100K Diagnostics-Operating Segments$2,769,600K Revenues$3,563,500K Intersegment Elimination-$5,200K Gross profit$1,025,100K Cost of revenues$2,538,400K Investment income$3,500K Operating income$396,600K Restructuring and othercharges$5,900K Goodwill and other assetimpairments$700K Amortization of intangiblesand other assets$69,500K Selling, general, andadministrative expenses$552,400K Earnings from operationsbefore income taxes$337,000K Other, net-$1,900K Equity method loss, net-$5,200K Interest expense$56,000K Net earnings$261,500K Provision for income taxes$75,500K Net earningsattributable to labcorp...$261,100K Less net earningsattributable to the...$400K

Labcorp_Logo-svg

LABCORP HOLDINGS INC. (LH)

Labcorp_Logo-svg

LABCORP HOLDINGS INC. (LH)